Which is a common side effect of beta-2 adrenergic agonists?

Which is a common side effect of beta-2 adrenergic agonists?

• A. Tachycardia
• B. Hypotension
• C. Angioedema
• D. Excessive salivation

Answer: (A)

Beta-2 adrenergic agonists are primarily used as bronchodilators in the treatment of conditions like asthma and chronic obstructive pulmonary disease (COPD). One of the well-known side effects of these medications is tachycardia, which refers to an increased heart rate. The mechanism behind this side effect is linked to the action of beta-2 receptors, which are primarily found in the lungs but also have some presence in the cardiovascular system. When these agonists stimulate beta-2 receptors, they can lead to a reflex increase in heart rate as a result of peripheral vasodilation and the body's compensatory mechanisms to maintain blood pressure and cardiac output. While beta-2 agonists are less commonly associated with significant cardiovascular effects compared to beta-1 agonists, tachycardia can still occur, especially with high doses or systemic administration. This side effect is particularly important for clinicians to consider when prescribing these medications, as it can be more pronounced in patients with pre-existing cardiovascular conditions.

Beta-2 adrenergic agonists are primarily used as bronchodilators in the treatment of conditions like asthma and chronic obstructive pulmonary disease (COPD). One of the well-known side effects of these medications is tachycardia, which refers to an increased heart rate.

The mechanism behind this side effect is linked to the action of beta-2 receptors, which are primarily found in the lungs but also have some presence in the cardiovascular system. When these agonists stimulate beta-2 receptors, they can lead to a reflex increase in heart rate as a result of peripheral vasodilation and the body's compensatory mechanisms to maintain blood pressure and cardiac output.

While beta-2 agonists are less commonly associated with significant cardiovascular effects compared to beta-1 agonists, tachycardia can still occur, especially with high doses or systemic administration. This side effect is particularly important for clinicians to consider when prescribing these medications, as it can be more pronounced in patients with pre-existing cardiovascular conditions.